PT1017667E - 2-amino-6-metil-7-acetil-tetralina e composicoes farmaceuticas para a prevencao e para o tratamento terapeutico de patologias inflamatorias e/ou de natureza autoimunitaria - Google Patents
2-amino-6-metil-7-acetil-tetralina e composicoes farmaceuticas para a prevencao e para o tratamento terapeutico de patologias inflamatorias e/ou de natureza autoimunitariaInfo
- Publication number
- PT1017667E PT1017667E PT98946706T PT98946706T PT1017667E PT 1017667 E PT1017667 E PT 1017667E PT 98946706 T PT98946706 T PT 98946706T PT 98946706 T PT98946706 T PT 98946706T PT 1017667 E PT1017667 E PT 1017667E
- Authority
- PT
- Portugal
- Prior art keywords
- inflammatory
- prevention
- pharmaceutical compositions
- therapeutic treatment
- patologies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97RM000568A IT1294931B1 (it) | 1997-09-22 | 1997-09-22 | Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1017667E true PT1017667E (pt) | 2004-04-30 |
Family
ID=11405257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98946706T PT1017667E (pt) | 1997-09-22 | 1998-09-22 | 2-amino-6-metil-7-acetil-tetralina e composicoes farmaceuticas para a prevencao e para o tratamento terapeutico de patologias inflamatorias e/ou de natureza autoimunitaria |
Country Status (17)
Country | Link |
---|---|
US (3) | US7041703B2 (pt) |
EP (1) | EP1017667B1 (pt) |
JP (1) | JP4181301B2 (pt) |
KR (1) | KR100583805B1 (pt) |
CN (1) | CN1145606C (pt) |
AT (1) | ATE254595T1 (pt) |
AU (1) | AU738565B2 (pt) |
BR (1) | BR9812368A (pt) |
CA (1) | CA2303943A1 (pt) |
DE (1) | DE69819922T2 (pt) |
DK (1) | DK1017667T3 (pt) |
ES (1) | ES2210820T3 (pt) |
HK (1) | HK1029099A1 (pt) |
IT (1) | IT1294931B1 (pt) |
NZ (1) | NZ503492A (pt) |
PT (1) | PT1017667E (pt) |
WO (1) | WO1999015494A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1294931B1 (it) * | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella |
IT1317049B1 (it) | 2000-06-23 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv. |
IT1317050B1 (it) * | 2000-06-23 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Tetraline 2,6,7-sostituite utili per la preparazione di un medicamentoad attivita' inibitrice della fosfodiesterasi iv. |
WO2002014286A1 (en) * | 2000-08-14 | 2002-02-21 | Teva Pharmaceutical Industries Ltd. | Preparation of risperidone |
US7125904B2 (en) | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
GB0504314D0 (en) * | 2005-03-02 | 2005-04-06 | Glaxo Group Ltd | Novel polymorph |
CN101768086B (zh) * | 2008-12-29 | 2014-03-26 | 北京富龙康泰生物技术有限公司 | 氨基甲醇衍生物及其盐类化合物及其合成方法和其药物用途 |
JP2020533365A (ja) | 2017-09-14 | 2020-11-19 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 医薬の製造に有用な新規化合物 |
CN115724758A (zh) * | 2021-08-24 | 2023-03-03 | 杭州中美华东制药有限公司 | 喜树碱衍生物中间体及其合成方法和利用中间体合成喜树碱衍生物的方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3919316A (en) * | 1974-08-05 | 1975-11-11 | Lilly Co Eli | 2-Aminodichlorotetralins |
DE2752659A1 (de) * | 1976-12-07 | 1978-06-08 | Sandoz Ag | Neue tetralinderivate, ihre herstellung und verwendung |
US4448990A (en) * | 1982-11-16 | 1984-05-15 | Eli Lilly And Company | Hydroxyaminotetralincarboxamides |
DE3660959D1 (de) * | 1985-06-26 | 1988-11-24 | Smithkline Beckman Corp | Benz-trisubstituted 2-aminotetralins |
IT1241988B (it) * | 1990-06-15 | 1994-02-02 | Sigma Tau Ind Farmaceuti | 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono |
IT1242043B (it) * | 1990-12-21 | 1994-02-02 | Sigma Tau Ind Farmaceuti | Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono. |
US5438150A (en) * | 1994-04-26 | 1995-08-01 | Syntex (U.S.A.) Inc. | Process for making 1-benzocycloalkyl-1,3-dihydroimidazole-2-thione derivatives |
IT1278045B1 (it) * | 1995-03-09 | 1997-11-17 | Sigma Tau Ind Farmaceuti | Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di |
IT1290910B1 (it) * | 1997-02-03 | 1998-12-14 | Sigma Tau Ind Farmaceuti | 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive |
IT1294931B1 (it) * | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella |
IT1294932B1 (it) * | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie |
-
1997
- 1997-09-22 IT IT97RM000568A patent/IT1294931B1/it active IP Right Grant
-
1998
- 1998-09-22 DE DE69819922T patent/DE69819922T2/de not_active Expired - Fee Related
- 1998-09-22 EP EP98946706A patent/EP1017667B1/en not_active Expired - Lifetime
- 1998-09-22 AT AT98946706T patent/ATE254595T1/de not_active IP Right Cessation
- 1998-09-22 ES ES98946706T patent/ES2210820T3/es not_active Expired - Lifetime
- 1998-09-22 CA CA002303943A patent/CA2303943A1/en not_active Abandoned
- 1998-09-22 DK DK98946706T patent/DK1017667T3/da active
- 1998-09-22 CN CNB988104598A patent/CN1145606C/zh not_active Expired - Fee Related
- 1998-09-22 KR KR1020007003077A patent/KR100583805B1/ko not_active IP Right Cessation
- 1998-09-22 AU AU93662/98A patent/AU738565B2/en not_active Ceased
- 1998-09-22 BR BR9812368-8A patent/BR9812368A/pt not_active Application Discontinuation
- 1998-09-22 PT PT98946706T patent/PT1017667E/pt unknown
- 1998-09-22 NZ NZ503492A patent/NZ503492A/xx unknown
- 1998-09-22 JP JP2000512805A patent/JP4181301B2/ja not_active Expired - Fee Related
- 1998-09-22 WO PCT/IT1998/000252 patent/WO1999015494A1/en active IP Right Grant
-
2000
- 2000-03-22 US US09/533,381 patent/US7041703B2/en not_active Expired - Fee Related
- 2000-10-26 HK HK00106848A patent/HK1029099A1/xx not_active IP Right Cessation
-
2001
- 2001-03-26 US US09/816,317 patent/US6849663B2/en not_active Expired - Fee Related
-
2003
- 2003-04-08 US US10/408,122 patent/US20030229148A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69819922T2 (de) | 2004-09-02 |
US20020123652A1 (en) | 2002-09-05 |
KR100583805B1 (ko) | 2006-05-26 |
BR9812368A (pt) | 2000-09-19 |
NZ503492A (en) | 2002-08-28 |
HK1029099A1 (en) | 2001-03-23 |
EP1017667A1 (en) | 2000-07-12 |
CN1145606C (zh) | 2004-04-14 |
US20030229148A1 (en) | 2003-12-11 |
DE69819922D1 (de) | 2003-12-24 |
US7041703B2 (en) | 2006-05-09 |
JP2001517649A (ja) | 2001-10-09 |
ITRM970568A1 (it) | 1999-03-22 |
ATE254595T1 (de) | 2003-12-15 |
DK1017667T3 (da) | 2004-03-29 |
US6849663B2 (en) | 2005-02-01 |
AU738565B2 (en) | 2001-09-20 |
AU9366298A (en) | 1999-04-12 |
JP4181301B2 (ja) | 2008-11-12 |
EP1017667B1 (en) | 2003-11-19 |
CA2303943A1 (en) | 1999-04-01 |
KR20010030671A (ko) | 2001-04-16 |
IT1294931B1 (it) | 1999-04-23 |
US20030158266A1 (en) | 2003-08-21 |
WO1999015494A1 (en) | 1999-04-01 |
CN1276782A (zh) | 2000-12-13 |
ES2210820T3 (es) | 2004-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO307968B1 (no) | Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav | |
EA199700135A1 (ru) | Ингибиторы клеточной адгезии | |
NL300258I2 (nl) | Farmaceutische samenstelling voor toepassing in debehandeling van. | |
DE69905170D1 (en) | Thiazolopyrimidinderivate | |
DE69020862D1 (de) | Anlage zur Verabreichung steriler Flüssigkeiten, insbesondere pharmazeutischer, nahrhafter oder energetischer Flüssigkeiten. | |
DE69905368D1 (en) | Oxydiertes thymosin beta 4 | |
PL323490A1 (en) | Tetralinic compounds exibiting acitity against multgiple-drug refractoriness | |
HK1029290A1 (en) | Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions. | |
SE9802937D0 (sv) | Novel compounds | |
PT1017667E (pt) | 2-amino-6-metil-7-acetil-tetralina e composicoes farmaceuticas para a prevencao e para o tratamento terapeutico de patologias inflamatorias e/ou de natureza autoimunitaria | |
BR9706908A (pt) | Composiçães para o tratamento de insuficiéncia renal compreendendo l-carnosina | |
PT1355906E (pt) | Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas | |
FR2799196B1 (fr) | Copolymeres reticules a base de copolymeres polycarboxyliques non reticules | |
IT8919735A0 (it) | Procedimento per la riduzione del cod da reflui industriali o urbani. | |
NO20005548D0 (no) | Mykobakterieinhibitorer | |
ES2190581T3 (es) | 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico. | |
WO1994018988A3 (en) | Use of heparins for the treatment of inflammatory or immunological diseases | |
ITRM920305A1 (it) | Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico. | |
ES2167942T3 (es) | Empleo de 2-aminotetralinas 6,7-sustituidas apropiadas para la preparacion de una composicion farmaceutica para el tratamiento terapeutico de patologias inflamatorias y/o autoinmunes. | |
GEP20074101B (en) | Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases | |
AU3439897A (en) | Pharmaceutical formulations containing colostrum and their use | |
IT8821136A0 (it) | Composizioni farmaceutiche per la litolisi di calcoli biliari secondari residui o ricorrenti. | |
FR2708283B1 (fr) | Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives. |